Viewing data from:

ZIPRASIDONE HYDROCHLORIDE

ANDA

ZIPRASIDONE HYDROCHLORIDE | A077565 | DR REDDYS LABORATORIES INC

4 strengths0 unique patents0 unique exclusivities

Reference Listed Drug: GEODON(TE code: AB)

Drug Pricing (NADAC)

National Average Drug Acquisition Cost — Week of 2026-07-15 | 16 NDCs

Highest NADAC/Unit

$0.3596

per ea

Lowest NADAC/Unit

$0.2734

per ea

Brand NDCs

Generic NDCs

NDC Description	NADAC/Unit	Unit	Type	Generic NADAC	Effective
00904627245ZIPRASIDONE HCL 80 MG CAPSULE	$0.3596	EA	Generic	—	2026-06-17
00904627208ZIPRASIDONE HCL 80 MG CAPSULE	$0.3596	EA	Generic	—	2026-06-17
16714083801ZIPRASIDONE HCL 80 MG CAPSULE	$0.3596	EA	Generic	—	2026-06-17
55111025960ZIPRASIDONE HCL 80 MG CAPSULE	$0.3596	EA	Generic	—	2026-06-17
00904627108ZIPRASIDONE HCL 60 MG CAPSULE	$0.3290	EA	Generic	—	2026-06-17
55111025860ZIPRASIDONE HCL 60 MG CAPSULE	$0.3290	EA	Generic	—	2026-06-17

Showing 6 of 16 NDCs.

Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.

API Supply Chain14 active DMFs7 inactive

12 active API suppliers hold Drug Master Files for this ingredient.

DR REDDYS LABORATORIES LTDZIPRASIDONE HYDROCHLORIDE USP

DMF 179222004

APOTEX INCZIPRASIDONE HYDROCHLORIDE

DMF 180502005

LUPIN LTDZIPRASIDONE HYDROCHLORIDE USP

DMF 180552005

WOCKHARDT LTDZIPRASIDONE HYDROCHLORIDE MONOHYDRATE

DMF 195032006

ZYDUS LIFESCIENCES LTDZIPRASIDONE HYDROCHLORIDE MONOHYDRATE USP

DMF 207692007

APITORIA PHARMA PRIVATE LTDZIPRASIDONE HYDROCHLORIDE USP (NON-STERILE DRUG SUBSTANCE)

DMF 210122007

DR REDDYS LABORATORIES LTDZIPRASIDONE HYDROCHLORIDE MONOHYDRATE

DMF 211472007

MEGAFINE PHARMA P LTDZIPRASIDONE HYDROCHLORIDE MONOHYDRATE USP (NON STERILE DRUG SUBSTANCE)

DMF 237392010

JUBILANT BIOSYS LTDZIPRASIDONE HYDROCHLORIDE USP

DMF 249552011

MACLEODS PHARMACEUTICALS LTDZIPRASIDONE HYDROCHLORIDE

DMF 250482011

AMINO CHEMICALS LTDZIPRASIDONE HYDROCHLORIDE MONOHYDRATE

DMF 272592013

RAKS PHARMA PVT LTDZIPRASIDONE HYDROCHLORIDE MONOHYDRATE, USP

DMF 311832016

APOTEX INCZIPRASIDONE HYDROCHLORIDE MONOHYDRATE USP

DMF 331732018

CHROMO LABORATORIES INDIA PRIVATE LTDZIPRASIDONE HYDROCHLORIDE USP

DMF 339912019

RANBAXY LABORATORIES LTDInactiveZIPRASIDONE HYDROCHLORIDE

DMF 180422005

CADILA HEALTHCARE LTDInactiveZIPRASIDONE HYDROCHLORIDE ANHYDROUS

DMF 189522005

TEVA PHARMACEUTICALS INDUSTRIES LTDInactiveZIPRASIDONE HYDROCHLORIDE

DMF 190052005

AMINO CHEMICALS LTDInactiveZIPRASIDONE HYDROCHLORIDE ANHYDROUS

DMF 201052006

WATSON PHARMA PRIVATE LTDInactiveZIPRASIDONE HYDROCHLORIDE MONOHYDRATE USP

DMF 243472010

QILU TIANHE PHARMACEUTICAL CO LTDInactiveZIPRASIDONE HYDROCHLORIDE (NON - STERILE API)

DMF 248372011

HETERO DRUGS LTDInactiveZIPRASIDONE HYDROCHLORIDE, USP

DMF 260452012

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Approval Letters

1 letter from Drugs@FDA

Date	Submission	Document
Apr 21, 2011	ORIG -1	View Letter (PDF)

Source: Drugs@FDA application documents.

Products (4)

Sort:

#001 — EQ 20MG BASE

0 patents0 exclusivities▴

CAPSULE;ORAL | Approved: Mar 2, 2012

No patent or exclusivity listings for this strength.

#002 — EQ 40MG BASE

0 patents0 exclusivities▾

CAPSULE;ORAL | Approved: Mar 2, 2012

#003 — EQ 60MG BASE

0 patents0 exclusivities▾

CAPSULE;ORAL | Approved: Mar 2, 2012

#004 — EQ 80MG BASE

0 patents0 exclusivities▾

CAPSULE;ORAL | Approved: Mar 2, 2012